Literature DB >> 27918548

Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array.

Bernd Zetsche1,2,3,4,5, Matthias Heidenreich1,2,3,4, Prarthana Mohanraju6, Iana Fedorova1,2,3,4,7,8, Jeroen Kneppers1,6, Ellen M DeGennaro1,9, Nerges Winblad1,2,3,4, Sourav R Choudhury1,2,3,4, Omar O Abudayyeh1,2,3,4,9, Jonathan S Gootenberg1,2,3,4,10, Wen Y Wu6, David A Scott1,2, Konstantin Severinov7,11,12, John van der Oost6, Feng Zhang1,2,3,4.   

Abstract

Targeting of multiple genomic loci with Cas9 is limited by the need for multiple or large expression constructs. Here we show that the ability of Cpf1 to process its own CRISPR RNA (crRNA) can be used to simplify multiplexed genome editing. Using a single customized CRISPR array, we edit up to four genes in mammalian cells and three in the mouse brain, simultaneously.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27918548      PMCID: PMC5225075          DOI: 10.1038/nbt.3737

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


Although multiplex gene editing is possible with Cas9, it requires relatively large constructs or simultaneous delivery of multiple plasmids , both of which are problematic for multiplex screens or in vivo applications. In contrast, Cpf1 only requires one Pol III promoter to drive several small crRNAs (39nt per crRNA). We confirmed that Cpf1 alone is sufficient for array processing[ using an artificial CRISPR pre-crRNA array consisting of four spacers separated by direct repeats (DRs) from the CRISPR locus of Francisella novicida (FnCpf1) and two Cpf1 orthologs with activity in mammalian cells, Acidaminococcus Cpf1 (AsCpf1) and Lachnospiraceae Cpf1 (LbCpf1) (). Small RNAseq showed that AsCpf1 cleavage products correlate to fragments resulting from cuts at the 5’ end of DR hairpins, identical to the cleavage pattern we observed in E.coli heterologously expressing FnCpf1 CRISPR systems[ (). We further validated these results by generating AsCpf1 mutants that are unable to process arrays. Guided by the crystal structure of AsCpf1[, we mutated five conserved amino acid residues likely to disrupt array processing (H800A, K809A, K860A, F864A, and R790A) [. All mutations interfered with pre-crRNA processing but not DNA cleavage activity in vitro (), an effect that was also observed for FnCpf1[. AsCpf1 recognizes specific nucleotides at the 5’ flank of the DR stem loop. Substitution of these nucleotides weakens or abolishes RNA cleavage (). Dosage tests with the five AsCpf1 mutants revealed that mutants K809A, K860A, F864A, and R790A show pre-crRNA processing when used at high concentration () or for extended incubation times (), but H800A was inactive regardless of dose and time. We next tested if this mutant retains DNase activity in human embryonic kidney (HEK) 293T cells using three guides. Insertion/deletion (indel) frequency at the DNMT1 and GRIN2b loci were identical between wild-type and H800A AsCpf1, whereas indel frequencies at the VEGFA locus were higher in cells transfected with wild-type AsCpf1, demonstrating that the RNA and DNA cleavage activity can be separated in mammalian cells (). Cpf1 mediated RNA cleavage needs to be considered when designing lenti-virus vectors for simultaneous expression of nuclease and guide (). Lenti virions carry a (+) strand RNA copy of the sequence flanked by long terminal repeats (LTR), allowing Cpf1 to bind and cleave at DR sequences. Hence, reversing the orientation of the DR is expected to result in (+) strand lenti RNAs not susceptible to Cpf1 mediated cleavage. We designed a lenti vector encoding AsCpf1 and a crRNA expression cassette. We transduced HEK293T cells with a MOI (multiplicity of infection) of <0.3 and analyzed indel frequencies in puromycin selected cells 10 days post infection. Using guides encoded on a reversed expression cassette targeting DNMT1, VEGFA, or GRIN2b resulted in robust indel formation for each targeted gene (). We leveraged the simplicity of Cpf1 crRNA maturation to achieve multiplex genome editing in HEK293T cells using customized CRISPR arrays. We chose four guides targeting different genes (DNMT1, EMX1, VEGFA, and GRIN2b) and constructed three arrays with variant DR and guide lengths for expression of pre-crRNAs (). Indel events were detected at each targeted locus in cells transfected with array-1 or -2. However, the crRNA targeting EMX1 resulted in indel frequencies of <2% when expressed from array-3. Overall, array-1 performed best, with all guides showing indel levels comparable to those mediated by single crRNAs (). Furthermore, small RNAseq confirmed that autonomous, Cpf1-mediated pre-crRNA processing occurs in mammalian cells (). Using arrays with guides in different orders resulted in similar indel frequencies, suggesting that positioning within an array is not crucial for activity (). To confirm that multiplex editing occurs within single cells, we generated AsCpf1-P2A-GFP constructs to enable fluorescence-activated cell sorting (FACS) of transduced single cells () and clonal expansion. We used next generation deep sequencing (NGS) to compare edited loci within clonal colonies derived from cells transfected with either pooled single guides or array-1. Focusing on targeted genes edited at every locus (indels ≥95%) shows that multiplex editing occurs more frequently in colonies transfected with array-1 (6.4% all targets, 12.8% three targets, 48.7% two targets) than in pooled transfection (2.4% all targets, 3.6% three targets, 11.9% two targets). We next tested multiplex genome editing in neurons using AsCpf1. We designed a gene-delivery system based on adeno-associated viral vectors (AAVs) for expression of AsCpf1. We generated a dual vector system in which AsCpf1 and the CRISPR-Cpf1 array were cloned separately (). We constructed a U6 promoter-driven Cpf1 array targeting the neuronal genes Mecp2, Nlgn3, and Drd1. This plasmid also included an green fluorescent protein (GFP) fused to the KASH nuclear transmembrane domain [ to enable FACS of targeted cell nuclei [. We first transduced mouse primary cortical neurons in vitro and observed robust expression of AsCpf1 and GFP-KASH one week after viral delivery. SURVEYOR nuclease assay on purified neuronal DNA confirmed indel formations in all three targeted genes (). Next, we tested whether AsCpf1 can be expressed in the brains of living mice for multiplex genome editing in vivo. We stereotactically injected our dual vector system in a 1:1 ratio into the hippocampal dentate gyrus (DG) of adult male mice. Four weeks after viral delivery we observed robust expression of AsCpf1 and GFP-KASH in the DG (). Consistent with previous studies [, we observed ~75% co-transduction efficiency of the dual viral vectors (). We isolated targeted DG cell nuclei by FACS () and quantified indel formation using NGS. We found indels in all three targeted loci with ~23%, ~38%, and ~51% indel formation in Mecp2, Nlgn3, and Drd1, respectively (). We quantified the effectiveness of biallelic disruption of the autosomal gene Drd1 and found ~47% of all sorted nuclei (i.e. ~87% of all Drd1-edited cells) harbored biallelic modifications (). Next, we quantified the multiplex targeting efficiency in single neuronal nuclei. Our results show that ~17% of all transduced neurons were modified in all three targeted loci (). Taken together, our results demonstrate the effectiveness of AAV-mediated delivery of AsCpf1 into the mammalian brain and simultaneous multi-gene targeting in vivo using a single array transcript. Taken together, these data highlight the utility of Cpf1 array processing in designing simplified systems for in vivo multiplex gene editing. Although multiplex gene editing is possible with Cas9, it requires relatively large constructs or simultaneous delivery of multiple plasmids [, both of which are problematic for multiplex screens or in vivo applications. In contrast, Cpf1 only requires one Pol III promoter to drive several small crRNAs (39nt per crRNA). Hence, this system has the potential to simplify guide RNA delivery for many genome editing applications where targeting of multiple genes is desirable.
  11 in total

1.  Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.

Authors:  Bernd Zetsche; Jonathan S Gootenberg; Omar O Abudayyeh; Ian M Slaymaker; Kira S Makarova; Patrick Essletzbichler; Sara E Volz; Julia Joung; John van der Oost; Aviv Regev; Eugene V Koonin; Feng Zhang
Journal:  Cell       Date:  2015-09-25       Impact factor: 41.582

2.  Dynamics and molecular interactions of linker of nucleoskeleton and cytoskeleton (LINC) complex proteins.

Authors:  Cecilia Ostlund; Eric S Folker; Jason C Choi; Edgar R Gomes; Gregg G Gundersen; Howard J Worman
Journal:  J Cell Sci       Date:  2009-10-20       Impact factor: 5.285

3.  Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system.

Authors:  Kabin Xie; Bastian Minkenberg; Yinong Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

4.  Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector.

Authors:  Ami M Kabadi; David G Ousterout; Isaac B Hilton; Charles A Gersbach
Journal:  Nucleic Acids Res       Date:  2014-08-13       Impact factor: 16.971

5.  In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9.

Authors:  Lukasz Swiech; Matthias Heidenreich; Abhishek Banerjee; Naomi Habib; Yinqing Li; John Trombetta; Mriganka Sur; Feng Zhang
Journal:  Nat Biotechnol       Date:  2014-10-19       Impact factor: 54.908

6.  Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA.

Authors:  Takashi Yamano; Hiroshi Nishimasu; Bernd Zetsche; Hisato Hirano; Ian M Slaymaker; Yinqing Li; Iana Fedorova; Takanori Nakane; Kira S Makarova; Eugene V Koonin; Ryuichiro Ishitani; Feng Zhang; Osamu Nureki
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

7.  Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells.

Authors:  Lior Nissim; Samuel D Perli; Alexandra Fridkin; Pablo Perez-Pinera; Timothy K Lu
Journal:  Mol Cell       Date:  2014-05-15       Impact factor: 17.970

8.  Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector system.

Authors:  Tetsushi Sakuma; Ayami Nishikawa; Satoshi Kume; Kazuaki Chayama; Takashi Yamamoto
Journal:  Sci Rep       Date:  2014-06-23       Impact factor: 4.379

9.  Optical control of mammalian endogenous transcription and epigenetic states.

Authors:  Silvana Konermann; Mark D Brigham; Alexandro Trevino; Patrick D Hsu; Matthias Heidenreich; Le Cong; Randall J Platt; David A Scott; George M Church; Feng Zhang
Journal:  Nature       Date:  2013-08-23       Impact factor: 49.962

10.  Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing.

Authors:  Shengdar Q Tsai; Nicolas Wyvekens; Cyd Khayter; Jennifer A Foden; Vishal Thapar; Deepak Reyon; Mathew J Goodwin; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-04-25       Impact factor: 54.908

View more
  243 in total

1.  Immediate, multiplexed and sequential genome engineering facilitated by CRISPR/Cas9 in Saccharomyces cerevisiae.

Authors:  Zhen-Hai Li; Hao Meng; Bin Ma; Xinyi Tao; Min Liu; Feng-Qing Wang; Dong-Zhi Wei
Journal:  J Ind Microbiol Biotechnol       Date:  2019-11-25       Impact factor: 3.346

Review 2.  Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics.

Authors:  Marliette R Matos; Seok-Man Ho; Nadine Schrode; Kristen J Brennand
Journal:  Mol Cell Neurosci       Date:  2020-07-23       Impact factor: 4.314

3.  Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.

Authors:  Ben Berkhout; Zongliang Gao; Elena Herrera-Carrillo
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors:  Ling Li; Shuo Hu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2018-04-18       Impact factor: 12.479

5.  Design and assessment of engineered CRISPR-Cpf1 and its use for genome editing.

Authors:  Bin Li; Chunxi Zeng; Yizhou Dong
Journal:  Nat Protoc       Date:  2018-04-05       Impact factor: 13.491

6.  Good guide, bad guide: spacer sequence-dependent cleavage efficiency of Cas12a.

Authors:  Sjoerd C A Creutzburg; Wen Y Wu; Prarthana Mohanraju; Thomas Swartjes; Ferhat Alkan; Jan Gorodkin; Raymond H J Staals; John van der Oost
Journal:  Nucleic Acids Res       Date:  2020-04-06       Impact factor: 16.971

7.  Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell-Free Transcription-Translation System.

Authors:  Ryan Marshall; Colin S Maxwell; Scott P Collins; Thomas Jacobsen; Michelle L Luo; Matthew B Begemann; Benjamin N Gray; Emma January; Anna Singer; Yonghua He; Chase L Beisel; Vincent Noireaux
Journal:  Mol Cell       Date:  2018-01-04       Impact factor: 17.970

Review 8.  CRISPR Tools for Systematic Studies of RNA Regulation.

Authors:  Jesse Engreitz; Omar Abudayyeh; Jonathan Gootenberg; Feng Zhang
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

9.  Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9-Cas12a platform.

Authors:  Thomas Gonatopoulos-Pournatzis; Michael Aregger; Kevin R Brown; Shaghayegh Farhangmehr; Ulrich Braunschweig; Henry N Ward; Kevin C H Ha; Alexander Weiss; Maximilian Billmann; Tanja Durbic; Chad L Myers; Benjamin J Blencowe; Jason Moffat
Journal:  Nat Biotechnol       Date:  2020-03-16       Impact factor: 54.908

10.  CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy.

Authors:  Rachel L Mintz; Madeleine A Gao; Kahmun Lo; Yeh-Hsing Lao; Mingqiang Li; Kam W Leong
Journal:  Adv Biosyst       Date:  2018-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.